In clinical practice, the attention given to sexual problems in patients with end-stage renal disease is low. In order to evaluate the erectile function in chronic renal failure patients undergoing hemodialysis (HD) as a renal replacement therapy in upper Egypt, we used the abridged version of the International Index of Erectile Function (IIEF-5). In all, 75 HD patients were subjected to clinical and laboratory investigations. The controls were 948 healthy males representing the general Egyptian population. The prevalence of erectile dysfunction (ED) among the HD patients was 82.5% compared to 30% among controls. The prevalence of ED in HD group was significantly higher than in controls. The prevalence of ED in HD patients o50 y was 80% and it was 88% in those Z50 y, while the prevalence of ED among controls was 28 and 69.8%, respectively. The prevalence of severe degree of ED was significantly higher in both groups compared to controls, while moderate degree of ED showed a statistical significance compared to controls in age groups o50 y and mild degree of ED showed a statistical significance compared to controls in age groups Z50 y. The univariate logistic regression analysis showed that age (r ¼ À0.3368, Po0.01), serum urea (r ¼ À0.5974, Po0.001), and creatinine level (r ¼ À0.5804, Po0.001) have a significant negative correlation with the presence of ED among HD patients, while serum hemoglobin (r ¼ 0.3396, Po0.001) and years of HD age (r ¼ 0.3147, Po0.01) have a significant positive correlation with the presence of ED among the HD patients. In view of the observed high prevalence of ED among the HD patients, we believe that a complete health evaluation of male HD patients should include a discussion about erectile function in the standard clinical care program of patients with renal disease.
Introduction
Erectile dysfunction (ED) is defined as the persistent inability to achieve or maintain an erection sufficient to permit satisfactory sexual performance. ED is commonly classified as organic, psychogenic or mixed, with organic ED being the most common type. 1 Organic ED, if not traumatic, is usually caused by abnormal function and responsiveness of the penile vasculature attributed to aging [2] [3] [4] or underlying disease. 5, 6 In clinical practice, the attention given to sexual problems in patients undergoing renal replacement therapy (RRT) is low. This may be caused by a lack of awareness of the high prevalence of sexual problems among these patients and of the modern therapeutic options for treatment. In addition, restraints in discussing sexual issues with the patients might be another contributing factor. 7 In 1972, Levy 8 conducted the first epidemiological survey of sexuality in patients with chronic renal disease, he suggested that sexuality was already impaired during the uremic phase before RRT, and in most patients sexuality did not improve after the start of RRT. Since then, the majority of epidemiological studies, although small in number, suggested that the prevalence of sexual problems or dysfunction in those patients is substantiated and needs further research.
The aim of our study is to identify the prevalence of ED among patients with chronic renal failure (CRF) undergoing hemodialysis (HD) as an RRT in upper Egypt by the use of the abridged version of the International Index of Erectile Function (IIEF-5), which is also known as the Sexual Health Inventory for Men (SHIM). The IIEF-5 addresses the USA National Institute of Health's definition of ED, discriminates well between men with and without ED, and reflects the severity of ED. It is also intended to complement clinical judgment 9 and aids in decreasing incorrect diagnosis of ED and decreasing the number of undiagnosed cases of ED. It is a useful diagnostic assessment as an initial screening instrument. 10 
Patients and methods

Recruitment of patients and controls
Male patients with CRF undergoing HD as RRT were recruited from the HD unit at Assiut University Hospitals. The included patients were married for the past 6 months, undergoing HD for at least 5 months, and aged between 20 and 69 y. These patients were representative of the Egyptian patients on RRT with regard to age distribution. The controls were recruited from the outpatient clinic of the Dermatology department at Assiut university hospitals as healthy, apparently normal males, married, with no disabling chronic disease, no history of severe illness, or no medication. They came with their relatives (dermatologic patient) but were not themselves dermatologic patients.
The ethical committee of Assiut University approved the study protocol and all participants signed an informed consent.
Finally, 75 patients undergoing HD as an RRT and 948 controls were affiliated to participate in answering the abridged version of the IIEF-5 questionnaire.
The study subjects were classified according to their age into two groups as follows: up to 49 y old: 50 HD patients and 895 controls; and more than 50 y old: 25 HD patients and 53 controls.
Clinical and laboratory data
Medical data were obtained for each patient from abstraction of dialysis records for the presence of hypertension, smoking, history of ischemic heart diseases, and duration of dialysis. Hemoglobin level, creatinine level, blood urea, albumin, and sugar were evaluated.
One investigator obtained the history of the patients and carried out physical examination, while another one interrogated the patients using the IIEF-5 questionnaire.
Methods
Patients and controls were invited to complete the abridged IIEF-5 after it has been translated to the Arabic language.
The IIEF-5 domains were erection confidence, erection firmness, maintenance frequency, maintenance ability, and intercourse satisfaction. Subjects' ED was measured and categorized according to the severity using a five-level ordinal scale based on their score on the IIEF-5. A cutoff score of 21 (range of score from 5 to 25) was used to define ED. Subjects with scores 21 or less were considered to have ED. ED was also classified likewise into five validated severity levels, ranging from no ED (22) (23) (24) (25) , mild (17) (18) (19) (20) (21) , mild to moderate (12) (13) (14) (15) (16) , moderate (8) (9) (10) (11) , moderate through to severe (5) (6) (7) .
In order to evaluate the erectile function in male CRF on HD, data obtained were compared with the age-matched individuals from the general Egyptian population using the same questionnaire.
Statistical analysis
The IIEF-5 score was represented by mean7s.d. The prevalence of the degree of ED severity was represented by numbers and percentages. The Mann-Whitney U-test was used to compare the mean values of IIEF-5 score between HD patients and controls for each age group. The chi-squared test (w 2 ) was used to compare the prevalence of the degree of severity of ED between HD patients and controls. Correlation coefficient (r) was calculated to study the relationship between age, serum urea, creatinine level, Hgb, and years of HD with the IIEF-5 score.
Univariate logistic regression analysis was performed among the HD patients to study the effect of age, smoking, urea, creatinine level, Hgb, and number of years of HD on each of the five domains of IIEF-5. Finally, for all previous statistical tests, significance was considered according to the level of significance (P-value) as follows: P40.05, not significant; Pr0.05, significance exists; Pr0.01, high significance; and Pr0.001, very high significance.
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Results
Patients
The final study cohort was made up of 75 patients on HD as an RRT and 948 controls. The mean7s.d. age was 40.8578.94 (range 20-69) y for the HD group and 38.0677.53 (range 22-62) y for controls. Among the HD group, 68% (n ¼ 51) were smokers, 61.3% (n ¼ 46) hypertensive, and 24% (n ¼ 18) had at least an attack of ischemic heart disease. In all, 6.7% of patients had been on HD for less than 1 y, 72% for 1-5 y, and 21.3% for more than 5 y. The mean7s.d. years of dialysis was 4.5573.86 y, with a minimum of 5 months and maximum of 21 y.
Prevalence and severity of ED
The prevalence of ED among the HD patients was 82.5% compared to 30% among controls. The prevalence of ED in the HD group was significantly higher than in controls (Po00.1). The prevalence of ED in HD patients at the age o50 and Z50 y was 80 and 69.8%, respectively, while the prevalence of ED in controls for the same age groups was 20 and 88% as shown in Figure 1 . The prevalence of ED was significantly higher in the age groups o50 y (Po0.01).
In all, 20% of those o50 y and 60% of those 450 y had severe degrees of ED among HD patients, yet severe ED was only significantly higher in younger age groups compared to controls. Among the HD patients aged o50 y, the prevalence of severe and moderate ED was significantly higher than controls (Po0.001), and for age group Z50 y, the prevalence of severe ED was significantly higher than controls (Po0.001). On the other hand, only a mild degree of ED showed a statistical significance compared to controls in age group Z50 y (Po0.05) as shown in Table 1 .
The prevalence of the five domains of the IIEF-5 was significantly higher than controls in all groups compared to controls.
Prevalence of risk factors
The univariate logistic regression analysis showed that age (r ¼ À0.3368, Po0.01), serum urea (r ¼ À0.5974, Po0.001), and creatinine level (r ¼ À0.5804, Po0.001) had a significant negative correlation with the presence of ED among HD patients, while serum hemoglobin (r ¼ 0.3396, Po0.001) and years of HD age (r ¼ 0.3147, Po0.01) had a significant positive correlation with the presence of ED among HD patients as shown in Figure 2 . Aging, increased serum urea, decreased creatinine level, presence of anemia, and years of hemodialysis correlated significantly with all domains of the IIEF-5 among the HD patients as shown in Table 2 .
Discussion
Despite the suspected association of ED and endstage renal disease and the impact that ED might have on the quality of life of these patients, the prevalence of ED in those patients has not been well characterized. The prevalence of ED among patients with CRF was first studied in 1973, when Levy 8 conducted the first epidemiological survey of sexuality in patients with a chronic renal disease, which was at that time limited to patients undergoing HD and patients after renal transplantation, and included both sexes. This study had strongly suggested that sexuality was already impaired during the uremic phase before RRT and, in most patients, sexuality did not improve after the start of RRT. In 1975, Abram and collaborators 11 reported that 20% of 32 married, male dialysis patients had no decrease in sexual functioning after the onset of kidney disease or the initiation of dialysis, 45% had reduced sexual potency after the onset of kidney disease, and the other 35% after beginning dialysis. 
ED in CRF patients undergoing hemodialysis M-EM Ali et al
In subsequent epidemiological studies, ED was found to be the most frequently reported sexual problem in male patients on RRT. A variety of definitions have been used to evaluate ED in the HD populations in seven limited studies, which included fewer than 34 HD patients. [12] [13] [14] [15] [16] [17] [18] Perhaps because of the varied definitions of ED and small sample size, the estimates of the prevalence ranged broadly from 41 to 93%. In another larger study in 53 male patients with CRF, ED occurred in 41.5 and 64.2% before and after HD, respectively. 19 Our results indicate that the prevalence of ED in HD patients is extremely high in absolute percentages (82.5%) and in comparison with the general Egyptian population (30%). A finding, which is consistent with prior, published studies.
Cerquiera et al 20 studied 119 patients on HD as an RRT using the International Index of Erectile Function and found that the prevalence of ED was 57.6% and in another recent study, Turk et al 21 reported 70% (104/148) prevalence of ED among HD patients. This estimated prevalence, together with our findings, indicates that despite the improvement introduced in the treatment of CRF patients, prevalence of ED remains high within the HD population.
The severity of ED in HD male patients has been reported infrequently in previous studies. Naya et al 22 showed that the degree of ED in HD patients was significantly more severe than controls in all age groups, while in another study Rosas et al 3 found that over four-fifth of male HD patients have some degree of ED and in 45% of them ED was severe. They added that 63% of subjects o50 y reported some degree of ED, of which one-third was severe. In 2002, Neto et al 23 found that 86.4% of HD males showed ED, complete ED was reported by 25.4%, moderate ED by 35.4%, and minimal ED by 24.6%. They added that males o50 y old had a prevalence of moderate/complete ED of 52.6%, whereas in men 450 y it was 70.5%. Our results showed that 20% of those o50 y and 60% of those Z50 y had severe degrees of ED among HD patients. One possible explanation for increased prevalence of severity among younger patients is that renal failure, accompanying illnesses, and medications are responsible for the abnormal function and responsiveness of penile vasculature in younger age, while in older age groups, in addition to these mentioned possible causes, aging contributes to the pathogenesis of ED in both patients and controls.
Age has been a matter for consideration in the origin of ED since the publication of the results of the Kisney Report 24 in 1948. In this study, the prevalence of ED in men o40 y was 1.9% and for men 460 y was 25%. Since this publication, age has been thought to be the most important causative factor for ED.
Although several studies did not comment on the relationship between age and ED in male renal failure patients, in our study, the prevalence of ED in HD patients was evaluated in two groups divided according to age. The prevalence of ED in HD patients was much higher than that in controls in age groups o50 y, but it was less in older age groups. We found that the score of erectile function decreased with age in HD patients as well as controls.
Our findings were in accordance with those of Rodger et al, 25 who found a strong association between age and prevalence of ED while evaluating 100 patients with CRF, but they did not compare this with its incidence in their general population.
The association between smoking and ED has been well documented in the literature. A little work had assessed this parameter in patients with ED and CRF. Cerqueira and collaborators 20 had found that the prevalence of ED was significantly higher in the group of smokers when compared to nonsmokers (26.9 vs 10% P ¼ 0.013). However, when logistic regression analysis was performed, it was seen that the age factor acted as a variable of confusion in relation to smoking habits. Naya et al 22 had found that smoking was not a risk factor for ED within HD patients. Our results supported this view as there was no significant correlation between smoking and ED within the HD group.
Renal anemia may, partially, participate in the pathogenesis of ED. A cohort of male dialysis patients has been identified who have continued to complain of sexual dysfunction after correction of anemia with erythropoietin therapy. Nevertheless, erythropoietin therapy is shown to improve sexual function in another male dialysis population. 26 In our study, the presence of anemia was significantly correlated with the presence of ED within the HD group. On the contrary, Naya et al 22 did not find a significant correlation between the presence of anemia and ED; also, Cerqueira et al 20 reported no significant correlation between anemia and ED, but in this study 77% of the patients had been using erythropoietin for more than 1 y and 90% of them showed normal levels of hematocrit and hemoglobin. We believe that the presence of anemia is an additional determinant risk factor for ED.
We have found a significant correlation between the duration of dialysis and the presence of ED among HD patients. In contrast to Rodger et al, 25 who reported that the incidence of ED was not related to the duration of dialysis and Naya et al 22 who further supported this view and found that the overall times of dialysis were not a risk factor for ED among HD patients. We believe that improvement in quality of life over years and correction of anemia may help in improving the erectile function in HD patients. In support of our view, Turk et al 21 reported that management of end-stage renal disease and correction of anemia may improve the quality of life. Also, we have found no significant correlation between the presence of ED and both hypertension and ischemic heart diseases. The majority of ED in CRF patients undergoing hemodialysis M-EM Ali et al previous studies concluded that they are not independent risk factors, as most of the patients with CRF have hypertension.
Conclusion
In view of the observed high prevalence of ED in HD patients, we believe that a complete health evaluation of male HD patients should include a discussion about erectile function. Strategies should be developed to incorporate sexological evaluation in the standard clinical care program of patients with renal disease.
